Ascent Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
15,670
-10,862
| -41% | -$750K | 0.04% | 318 |
|
|
2025
Q1 | $1.84M | Buy |
26,532
+6,218
| +31% | +$432K | 0.08% | 246 |
|
|
2024
Q4 | $1.75M | Sell |
20,314
-2,841
| -12% | -$244K | 0.13% | 193 |
|
|
2024
Q3 | $2.76M | Buy |
23,155
+286
| +1% | +$34.1K | 0.21% | 126 |
|
|
2024
Q2 | $3.26M | Buy |
22,869
+3,670
| +19% | +$524K | 0.27% | 94 |
|
|
2024
Q1 | $2.47M | Buy |
19,199
+795
| +4% | +$102K | 0.22% | 131 |
|
|
2023
Q4 | $2.22M | Buy |
18,404
+9,057
| +97% | +$1.09M | 0.21% | 134 |
|
|
2023
Q3 | $935K | Sell |
9,347
-715
| -7% | -$71.5K | 0.1% | 239 |
|
|
2023
Q2 | $952K | Sell |
10,062
-1,664
| -14% | -$157K | 0.1% | 242 |
|
|
2023
Q1 | $933K | Buy |
11,726
+532
| +5% | +$42.3K | 0.1% | 242 |
|
|
2022
Q4 | $757K | Sell |
11,194
-256
| -2% | -$17.3K | 0.09% | 249 |
|
|
2022
Q3 | $623K | Sell |
11,450
-1,566
| -12% | -$85.2K | 0.08% | 258 |
|
|
2022
Q2 | $755K | Sell |
13,016
-20
| -0.2% | -$1.16K | 0.09% | 243 |
|
|
2022
Q1 | $724K | Buy |
13,036
+4,648
| +55% | +$258K | 0.08% | 257 |
|
|
2021
Q4 | $400K | Buy |
+8,388
| New | +$400K | 0.05% | 334 |
|